Literature DB >> 9202757

Metabolism of food-derived heterocyclic amines in nonhuman primates.

E G Snyderwine1, R J Turesky, K W Turteltaub, C D Davis, N Sadrieh, H A Schut, M Nagao, T Sugimura, U P Thorgeirsson, R H Adamson, S S Thorgeirsson.   

Abstract

During the cooking of meats, several highly mutagenic heterocyclic amines (HCAs) are produced. Three HCAs, IQ, MeIQx, and PhIP have been under study for carcinogenicity in cynomolgus monkeys, and to date, IQ has been shown to be a potent hepatocarcinogen. Concomitantly, the metabolic processing of these HCAs has been examined. Metabolism studies show that the potent hepatocarcinogenicity of IQ is associated with the in vivo metabolic activation of IQ via N-hydroxylation and the formation of DNA adducts. In monkeys undergoing carcinogen bioassay with IQ, N-hydroxylation was confirmed by the presence of the N-hydroxy-N-glucuronide conjugate of IQ in urine. The N-hydroxylation of IQ appears to be carried out largely by hepatic CYP3A4 and/or CYP2C9/10, and not by CYP1A2, an isoform not expressed in liver of this species. Notably MeIQx is poorly activated in cynomolgus monkeys and lacks the potency of IQ to induce hepatocellular carcinoma after a 5-year dosing period. The poor activation of MeIQx appears to be due to the lack of constitutive expression of CYP1A2 and an inability of other cytochromes P450, such as CYP3A4 and CYP2C9/10, to N-hydroxylate the quinoxalines. MeIQx is detoxified in monkeys largely by conjugation with glucuronide at the N-1 position. Although the carcinogenicity of PhIP is not yet known, the metabolic data suggest that PhIP will be carcinogenic in this species. PhIP is metabolically activated in vivo in monkeys by N-hydroxylation, as discerned by the presence of the N-hydroxy-N-glucuronide conjugate in urine, bile, and plasma. PhIP also produces DNA adducts that are widely distributed in tissues. The results from these studies support the importance of N-hydroxylation in the carcinogenicity of HCAs in nonhuman primates and by analogy, the importance of this metabolic activation step in the possible carcinogenicity of dietary HCAs in humans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202757     DOI: 10.1016/s0027-5107(97)00044-4

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  12 in total

1.  1H nuclear magnetic resonance spectroscopy-based studies of the metabolism of food-borne carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline by human intestinal microbiota.

Authors:  Christèle Humblot; Bruno Combourieu; Marja-Liisa Väisänen; Jean-Pierre Furet; Anne-Marie Delort; Sylvie Rabot
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

2.  A comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach.

Authors:  Chi Chen; Xiaochao Ma; Michael A Malfatti; Kristopher W Krausz; Shioko Kimura; James S Felton; Jeffrey R Idle; Frank J Gonzalez
Journal:  Chem Res Toxicol       Date:  2007-02-06       Impact factor: 3.739

3.  Identification of fipronil metabolites by time-of-flight mass spectrometry for application in a human exposure study.

Authors:  Rebecca L McMahen; Mark J Strynar; Sonia Dagnino; David W Herr; Virginia C Moser; Stavros Garantziotis; Erik M Andersen; Danielle L Freeborn; Larry McMillan; Andrew B Lindstrom
Journal:  Environ Int       Date:  2015-02-17       Impact factor: 9.621

Review 4.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

5.  A comprehensive approach to the profiling of the cooked meat carcinogens 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and their metabolites in human urine.

Authors:  Dan Gu; Lynn McNaughton; David Lemaster; Brian G Lake; Nigel J Gooderham; Fred F Kadlubar; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2010-04-19       Impact factor: 3.739

6.  Biomonitoring of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its carcinogenic metabolites in urine.

Authors:  Jean-Marie Fede; Anup P Thakur; Nigel J Gooderham; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2009-06       Impact factor: 3.739

7.  Intake of Meat Mutagens and Risk of Prostate Cancer in a Cohort of U.S. Health Professionals.

Authors:  Sabine Rohrmann; Katharina Nimptsch; Rashmi Sinha; Walter C Willett; Edward L Giovannucci; Elizabeth A Platz; Kana Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-07-29       Impact factor: 4.254

Review 8.  Metabolism and biomarkers of heterocyclic aromatic amines in humans.

Authors:  Medjda Bellamri; Scott J Walmsley; Robert J Turesky
Journal:  Genes Environ       Date:  2021-07-16

Review 9.  Chemical carcinogenesis studies in nonhuman primates.

Authors:  Shozo Takayama; Unnur P Thorgeirsson; Richard H Adamson
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2008       Impact factor: 3.493

10.  Analysis of the Functional Polymorphism in the Cytochrome P450 CYP2C8 Gene rs11572080 with Regard to Colorectal Cancer Risk.

Authors:  José M Ladero; José A G Agúndez; Carmen Martínez; Gemma Amo; Pedro Ayuso; Elena García-Martín
Journal:  Front Genet       Date:  2012-12-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.